Gilead Sciences, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 250,741 | 0.2% | 2,042,825 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 206,922 | 0.2% | 1,864,072 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 60,037 | 0.1% | 541,512 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 59,749 | 0.1% | 533,240 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 27,718 | 0.0% | 300,074 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 31,334 | 0.0% | 373,760 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 27,313 | 0.0% | 398,130 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 21,585 | 0.0% | 294,640 | 3/31/2024 |
| 2023 Q4 | 2/16/2024 | 27,435 | 0.0% | 338,736 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 26,013 | 0.0% | 347,205 | 9/30/2023 |
| 2023 Q2 | 5/17/2024 | 63,735 | 0.1% | 826,910 | 6/30/2023 |
| 2023 Q1 | 5/17/2024 | 100,282 | 0.2% | 1,208,648 | 3/31/2023 |
| 2022 Q4 | 5/17/2024 | 56,001 | 0.1% | 652,360 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 33,189 | 0.1% | 538,064 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 35,620 | 0.1% | 576,244 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 38,994 | 0.1% | 655,893 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 34,175 | 0.0% | 465,860 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 58,960 | 0.1% | 844,022 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 48,091 | 0.1% | 698,437 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 15,924 | 0.0% | 246,286 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 29,922 | 0.1% | 524,193 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 86,679 | 0.2% | 1,372,154 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 107,935 | 0.3% | 1,403,174 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 143,157 | 0.5% | 1,914,856 | 3/31/2020 |
| 2019 Q4 | 3/12/2020 | 99,397 | 0.3% | 1,530,276 | 12/31/2019 |